Expansion & Upsell Pipeline Intelligence

Q3 FY2025 • Vanta Security • Goal: Which existing accounts have the highest expansion signal right now, and is our CSM/AE capacity allocated to protect 115% NRR this quarter?

Expansion Pipeline Coverage
2.6×
+0.3× vs. target 2.3×
Trailing 12M NRR
112.3%
-2.7% vs. 115% goal
Upsell Conv. Rate (T1)
58.4%
+4.2% QoQ
Cross-sell Attach
31%
-1.8% vs. Q2
Avg. Days to Close
42
-6d vs. new logo (48d)
Whitespace Opps
34
Signal score >72, no opp

Expansion Pipeline by Account Tier & Stage ($4.2M total)

Product Usage Expansion Signal Distribution

Signal score = f(seat utilization, feature adoption, API usage, support tier). 187 accounts scored.

CSM-to-AE Handoff Conversion Funnel

72% of high-signal accounts convert to qualified expansion opps; 61% close.

Account Health Score Momentum (90-day trend)

Week 6 pricing increase triggered health dip across 43 accounts; 31 have since recovered.

Time-to-Expansion-Close by Tier (days)

T1 expansion closes 14d faster than new logo; T2/T3 similar velocity.

High-Signal Whitespace Accounts (34 accounts • No open expansion opp)

Account Tier ARR Signal Score Seat Util. Feature Adoption Last Touch Health Action
Apex Financial T1 $180K 88 94% 81% 4d ago Healthy
BlueCrest Tech T1 $165K 84 88% 76% 2d ago Healthy
Catalyst Labs T2 $92K 82 91% 68% 7d ago Neutral
Evergreen Systems T1 $142K 79 85% 72% 5d ago Healthy
Foundry Inc T2 $78K 77 89% 64% 3d ago Healthy
Horizon Partners T2 $85K 76 82% 69% 9d ago Neutral
Meridian Group T1 $134K 75 80% 74% 6d ago Healthy
NorthStar Ventures T2 $68K 74 86% 61% 11d ago Neutral

Land-and-Expand Cohort ARR Growth

2023 cohort at 142% of initial ARR; 2024 at 118% (12 months in).

Expansion Win Rate vs. Competitive Displacement

Expansion Win Rate
67.2%
+3.1% QoQ
T158.4%
T271.6%
T373.8%
Competitive Displacement
4.2%
+0.8% QoQ
Vanta → Drata2.1%
Vanta → Secureframe1.4%
Vanta → Other0.7%
Churn-Risk-Adjusted Forecast
$3.8M
90.5% of $4.2M pipeline
Avg. Expansion Deal Size
$22.5K
T1: $38K | T2: $18K | T3: $9K
CSM Handoff Success
72%
High-signal → Qualified Opp
Dashboard Notes: Week 6 pricing increase communication triggered health score dip across 43 accounts; recovery monitored in Health Momentum chart. Apex Financial flagged critical: $180K ARR, 88 signal score, 94% seat utilization, no open expansion opp — immediate CSM outreach required. Cross-sell attach rate decline attributed to Q3 product roadmap delay (Vanta Risk module launch moved to Q4). NRR gap to 115% target driven by T1 upsell velocity; coverage ratio healthy but conversion needs acceleration. Data as of Sept 28, 2025.